TOKYO -- U.S. drugmaker Pfizer lifted spirits worldwide this week with word that its vaccine candidate was found to be "more than 90% effective in preventing COVID-19."
Questions remain over new technology, long-term immunity and limited supply
TOKYO -- U.S. drugmaker Pfizer lifted spirits worldwide this week with word that its vaccine candidate was found to be "more than 90% effective in preventing COVID-19."